Relapsed /Refractory DLBCL
Oncology·MeSH: Lymphoma, Large B-Cell, Diffuse
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| obinutuzumab | GH Research PLC (GHRS) |
Frequently asked questions
How many drugs are in development for Relapsed /Refractory DLBCL?
BioSniper tracks 1 drug in development for Relapsed /Refractory DLBCL across 1 company.
How many clinical trials target Relapsed /Refractory DLBCL?
There are 1 clinical trial targeting Relapsed /Refractory DLBCL tracked by BioSniper.
Deep-dive into Relapsed /Refractory DLBCL
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis